about
Predictive value of ovarian stroma measurement for cardiovascular risk in polycyctic ovary syndrome: a case control study.Intermittent low-dose finasteride is as effective as daily administration for the treatment of hirsute women.Endometriosis is characterized by an impaired localization of laminin-5 and alpha3beta1 integrin receptor.Effect of finasteride on ovulation induction in nonresponder (hyperandrogenic) polycystic ovary syndrome (PCOS) women.Tolerability and cardiovascular complications of outpatient diagnostic minihysteroscopy compared with conventional hysteroscopy.Possible direct influence of complement 3 in decreasing insulin sensitvity in a cohort of overweight and obese subjects.Ursodeoxycholic acid therapy in pregnant women with cholestasis.Comparison of Diane 35 and Diane 35 plus finasteride in the treatment of hirsutismFree testosterone plasma levels are negatively associated with the intima-media thickness of the common carotid artery in overweight and obese glucose-tolerant young adult menBlood to the cornual area of the uterus is mainly supplied from the ovarian artery in the follicular phase and from the uterine artery in the luteal phaseChromosome analysis of spontaneous abortions after in vitro fertilization (IVF) and intracytoplasmic sperm injection (ICSI)Inhibitory effect of obesity on gonadotropin, estradiol, and inhibin B levels in fertile womenEndometrial micropolyps at fluid hysteroscopy suggest the existence of chronic endometritisDetection of chronic endometritis at fluid hysteroscopyIntussusception and incarceration of a fallopian tube: report of 2 atypical cases, with differential considerations, clinical evaluation, and current management strategiesIntrauterine bone fragments and endometrial plaque of osseous metaplasiaIsobaric laparoscopy using LaparoTenser system in surgical gynecologic oncologyPivotal points in interstitial pregnancy: new insights in conservative medical treatment of non-ruptured interstitial pregnancy
P50
Q34393333-2F20A6C4-8C07-46E6-B325-9F3C478C71EEQ45063806-E2FF2D38-427F-4DF3-A0B3-6EABE79CD281Q45191606-1E537CD7-4758-4783-9AC0-B8E0F52CAA11Q46063747-98486E41-CD49-4758-AF3B-D720D81ADE86Q48944233-E89A74EA-4A1F-4392-9E08-10068DD5584AQ51328491-53AA03B1-FBF9-4D12-8CC9-2F02C87F8196Q54020033-1B2A58FD-A97F-46BB-A04E-1211BEE508DFQ56673653-6049C0ED-B24D-4787-90DA-74F06F56374BQ73563388-215B373E-8697-4263-BAAF-C67497B164B9Q76388825-1E91C34E-0ABE-4712-806E-BB8DA11C5FB6Q77069351-254FC5B1-AC5F-418B-91E5-2865CE7662E2Q79393997-D3605340-C6B1-401D-A90F-1F12960081B9Q81448054-8DCD4BED-CBB7-48DA-9558-511CEEEA5025Q81595270-F38FFF9E-BC24-4D34-B299-CC47A6DCCD20Q83481957-BFAC67E1-10B9-4A82-B03E-E2C982D07853Q83535985-34717204-D8E8-4272-A539-7925899058F7Q86671381-B320B6A6-A4E9-4185-9F78-3794E957B76EQ86986825-6767EB83-3EDA-43F0-80F9-5899FF7E1991
P50
description
hulumtues
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Massimo Tartagni
@ast
Massimo Tartagni
@en
Massimo Tartagni
@es
Massimo Tartagni
@nl
Massimo Tartagni
@sl
type
label
Massimo Tartagni
@ast
Massimo Tartagni
@en
Massimo Tartagni
@es
Massimo Tartagni
@nl
Massimo Tartagni
@sl
prefLabel
Massimo Tartagni
@ast
Massimo Tartagni
@en
Massimo Tartagni
@es
Massimo Tartagni
@nl
Massimo Tartagni
@sl
P106
P1153
56271277100
P21
P31
P496
0000-0001-8349-8358
P569
2000-01-01T00:00:00Z